Diagonal Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesBlood & Organ Banks · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
300 Technology Sq Ste 8, Cambridge, Mass...Website
www.diagonaltx.comRevenue
<$5 MillionIndustry
ZI Rank: 3
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
3
4
3
5
6
3
About Diagonal Therapeutics
Based in Boston, Massachusetts, Diagonal Therapeutics is a biotechnology company with a focus on rare agonist antibodies.Explore more
Popular SearchesDiagonal Therapeutics IncDiagonalSIC Code 28,283NAICS Code 32,325Show moreDiagonal Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Diagonal Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Diagonal Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Diagonal Therapeutics has new funding data
Check out if Diagonal Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Diagonal Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Diagonal Therapeutics
Check if Diagonal Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Diagonal Therapeutics launches new products
Earning: See what the market has to say on Diagonal Therapeutics recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Diagonal Therapeutics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Diagonal Therapeutics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Diagonal Therapeutics.
Diagonal Therapeutics financials insights
Gather financial insights about Diagonal Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series A
$128M
Diagonal Therapeutics Tech Stack
A closer look at the technologies used by Diagonal Therapeutics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
New Hire
Executive Move
Executive Moves, New Hire
Diagonal Therapeutics News & Media
Diagonal Therapeutics Expands Executive Leadership Team, Appoints Industry Veteran Jonathan Piazza as Chief Financial Officer
WATERTOWN, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Diagonal Therapeutics, a biotechnology company developing disease-modifying clustering antibodies that correct dysregulated signaling in severe genetic diseases, today announced the appointment of Jonathan Piazza as Chief Financial Officer (CFO). Jonathan is a seasoned biotech executive with more than 25 years of expertise spanning company building, strategic finance, capital markets and M&A.Diagonal Therapeutics Lands $125 Million Series B
WATERTOWN, MA, Diagonal Therapeutics, a biotechnology company, announced the closing of an oversubscribed $125 million Series B financing co-led by Sanofi Ventures and Janus Henderson Investors.Diagonal Therapeutics Announces Oversubscribed $125 Million Series B Financing to Advance Clinical Development of Disease-Modifying, Clustering Antibody Pipeline
Financing co-led by Sanofi Ventures and Janus Henderson Investors, with participation from new investors Deep Track Capital, EcoR1 Capital, Logos Capital, Balyasny Asset Management L.P., Woodline Partners LP and all existing investorsDiagonal Therapeutics to Present Insights from HHT IMPACT, a Natural History Study Initiated in Partnership with Cure HHT, at ASH 2025
Preliminary results indicate HHT patients are significantly impacted by bleeding events, with consistency in severity reporting at months one and three of the study
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Diagonal Therapeutics
Sign Up For FreeTo access detailed company insights
Based in Boston, Massachusetts, Diagonal Therapeutics is a biotechnology company with a focus on rare agonist antibodies.... Read More
